These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. B7-H3-targeted CAR-T cell therapy for solid tumors. Li G; Wang H; Wu H; Chen J Int Rev Immunol; 2022; 41(6):625-637. PubMed ID: 35855615 [TBL] [Abstract][Full Text] [Related]
4. B7-H3/CD276: An Emerging Cancer Immunotherapy. Zhou WT; Jin WL Front Immunol; 2021; 12():701006. PubMed ID: 34349762 [TBL] [Abstract][Full Text] [Related]
5. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy. Picarda E; Ohaegbulam KC; Zang X Clin Cancer Res; 2016 Jul; 22(14):3425-3431. PubMed ID: 27208063 [TBL] [Abstract][Full Text] [Related]
6. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity. Loo D; Alderson RF; Chen FZ; Huang L; Zhang W; Gorlatov S; Burke S; Ciccarone V; Li H; Yang Y; Son T; Chen Y; Easton AN; Li JC; Rillema JR; Licea M; Fieger C; Liang TW; Mather JP; Koenig S; Stewart SJ; Johnson S; Bonvini E; Moore PA Clin Cancer Res; 2012 Jul; 18(14):3834-45. PubMed ID: 22615450 [TBL] [Abstract][Full Text] [Related]
8. B7 homolog 3 in pancreatic cancer. Perovic D; Dusanovic Pjevic M; Perovic V; Grk M; Rasic M; Milickovic M; Mijovic T; Rasic P World J Gastroenterol; 2024 Aug; 30(31):3654-3667. PubMed ID: 39193002 [TBL] [Abstract][Full Text] [Related]
9. Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity. Xu Y; Xiao Y; Luo C; Liu Q; Wei A; Yang Y; Zhao L; Wang Y Int Immunopharmacol; 2020 Jul; 84():106584. PubMed ID: 32422527 [TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy. Zhao B; Li H; Xia Y; Wang Y; Wang Y; Shi Y; Xing H; Qu T; Wang Y; Ma W J Hematol Oncol; 2022 Oct; 15(1):153. PubMed ID: 36284349 [TBL] [Abstract][Full Text] [Related]
11. B7-H3 in Brain Malignancies: Immunology and Immunotherapy. Guo X; Chang M; Wang Y; Xing B; Ma W Int J Biol Sci; 2023; 19(12):3762-3780. PubMed ID: 37564196 [TBL] [Abstract][Full Text] [Related]
12. B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell Lung Cancer? Malapelle U; Parente P; Pepe F; Di Micco MC; Russo A; Clemente C; Graziano P; Rossi A Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555714 [TBL] [Abstract][Full Text] [Related]
13. Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors. Yang M; Tang X; Zhang Z; Gu L; Wei H; Zhao S; Zhong K; Mu M; Huang C; Jiang C; Xu J; Guo G; Zhou L; Tong A Theranostics; 2020; 10(17):7622-7634. PubMed ID: 32685008 [No Abstract] [Full Text] [Related]
14. Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer. Scribner JA; Brown JG; Son T; Chiechi M; Li P; Sharma S; Li H; De Costa A; Li Y; Chen Y; Easton A; Yee-Toy NC; Chen FZ; Gorlatov S; Barat B; Huang L; Wolff CR; Hooley J; Hotaling TE; Gaynutdinov T; Ciccarone V; Tamura J; Koenig S; Moore PA; Bonvini E; Loo D Mol Cancer Ther; 2020 Nov; 19(11):2235-2244. PubMed ID: 32967924 [TBL] [Abstract][Full Text] [Related]
15. B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy. Ma J; Ma P; Zhao C; Xue X; Han H; Liu C; Tao H; Xiu W; Cai J; Zhang M Oncotarget; 2016 May; 7(20):29480-91. PubMed ID: 27121051 [TBL] [Abstract][Full Text] [Related]
16. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration. Li L; Nian S; Liu Q; Zhang B; Jimu W; Li C; Huang Z; Hu Q; Huang Y; Yuan Q Int Immunopharmacol; 2024 May; 132():111926. PubMed ID: 38552297 [TBL] [Abstract][Full Text] [Related]
17. Development of DS-5573a: A novel afucosylated mAb directed at B7-H3 with potent antitumor activity. Nagase-Zembutsu A; Hirotani K; Yamato M; Yamaguchi J; Takata T; Yoshida M; Fukuchi K; Yazawa M; Takahashi S; Agatsuma T Cancer Sci; 2016 May; 107(5):674-81. PubMed ID: 26914241 [TBL] [Abstract][Full Text] [Related]
18. Targeting B7-H3-A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment. Rasic P; Jeremic M; Jeremic R; Dusanovic Pjevic M; Rasic M; Djuricic SM; Milickovic M; Vukadin M; Mijovic T; Savic D Molecules; 2023 Apr; 28(8):. PubMed ID: 37110590 [TBL] [Abstract][Full Text] [Related]
19. B7-H3 in tumors: friend or foe for tumor immunity? Li G; Quan Y; Che F; Wang L Cancer Chemother Pharmacol; 2018 Feb; 81(2):245-253. PubMed ID: 29299639 [TBL] [Abstract][Full Text] [Related]
20. B7-H3-targeted Radioimmunotherapy of Human Cancer. Kasten BB; Ferrone S; Zinn KR; Buchsbaum DJ Curr Med Chem; 2020; 27(24):4016-4038. PubMed ID: 30836909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]